On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002855:Chromatography, Thin Layer; D004359:Drug Therapy, Combination; D005260:Female; D006207:Half-Life; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D013053:Spectrophotometry; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D007538:Isoniazid; D012293:Rifampin